Starpharma Holdings reported AUD15.41M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Medical Developments International AUD 17.84M 219K Jun/2025
Mesoblast USD 129.57M 31.58M Dec/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025